ATP1A1 and Charcot-Marie-Tooth disease: Thus, the phenotypic spectrum of ATP1A1-related CMT appears to expand from the demyelinating to the axonal end of the spectrum, and this should be taken into consideration when investigating demyelinating CMT neuropathies.